Please use this identifier to cite or link to this item: http://buratest.brunel.ac.uk/handle/2438/10490
Title: Effect of folic acid supplementation in pregnancy on preeclampsia: The folic acid clinical trial study
Authors: Wen, SW
Champagne, J
Rennicks White, R
Coyle, D
Fraser, W
Smith, G
Fergusson, D
Walker, MC
Keywords: Preeclampsia;Folic acid supplementation;Folic acid clinical trial;Pregnant women
Issue Date: 2013
Publisher: Hindawi Publishing Corporation
Citation: Journal of Pregnancy, 2013: 294312, (2013)
Abstract: Preeclampsia (PE) is hypertension with proteinuria that develops during pregnancy and affects at least 5% of pregnancies. The Effect of Folic Acid Supplementation in Pregnancy on Preeclampsia: the Folic Acid Clinical Trial (FACT) aims to recruit 3,656 high risk women to evaluate a new prevention strategy for PE: supplementation of folic acid throughout pregnancy. Pregnant women with increased risk of developing PE presenting to a trial participating center between 80/7 and 166/7 weeks of gestation are randomized in a 1: 1 ratio to folic acid 4.0 mg or placebo after written consent is obtained. Intent-to-treat population will be analyzed. The FACT study was funded by the Canadian Institutes of Health Research in 2009, and regulatory approval from Health Canada was obtained in 2010. A web-based randomization system and electronic data collection system provide the platform for participating centers to randomize their eligible participants and enter data in real time. To date we have twenty participating Canadian centers, of which eighteen are actively recruiting, and seven participating Australian centers, of which two are actively recruiting. Recruitment in Argentina, UK, Netherlands, Brazil, West Indies, and United States is expected to begin by the second or third quarter of 2013. This trial is registered with NCT01355159. © 2013 Shi Wu Wen et al.
Description: Copyright © 2013 Shi Wu Wen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
URI: http://www.hindawi.com/journals/jp/2013/294312/
http://bura.brunel.ac.uk/handle/2438/10490
DOI: http://dx.doi.org/10.1155/2013/294312
ISSN: 2090-2727
2090-2735
Appears in Collections:Health Economics Research Group (HERG)

Files in This Item:
File Description SizeFormat 
Fulltext.pdf575.78 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.